Obesity as a modifiable risk factor in patients with chronic kidney disease
- 30 October 2025
- journal article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
Abstract
Obesity and metabolic syndrome (MS) represent two of the most pressing global public health challenges, often coexisting and synergistically increasing the risk of cardiovascular and renal complications. Over the past decade, advances in our understanding of the pathophysiological mechanisms underlying chronic kidney disease (CKD) have reshaped our approach to patients with coexisting obesity and CKD. The identification of distinct phenotypes associated with an elevated risk of CKD progression and cardiovascular events, along with the development of novel therapeutic strategies, has contributed to a paradigm shift in clinical management. Currently, therapeutic options such as sodium–glucose co-transporter 2 inhibitors, glucagon-like peptide-1 receptor agonists and their combination with the non-steroidal mineralocorticoid receptor antagonist finerenone—when added to standard renin–angiotensin–aldosterone system blockade—are available and have shown potential for cardiorenal protection in patients with obesity and/or MS and CKD. In this review, we highlight the complex interplay between obesity and CKD, emphasizing the need for an integrated, multidisciplinary approach. The use of multitargeted therapeutic strategies holds promise in substantially altering the natural course of disease progression, ultimately improving patient outcomes.Keywords
This publication has 119 references indexed in Scilit:
- Comparison of the effects of Liraglutide, Tirzepatide, and Retatrutide on diabetic kidney disease in db/db miceEndocrine, 2024
- The Kidney in Obesity: Current Evidence, Perspectives and ControversiesCurrent Obesity Reports, 2024
- Metabolic Bariatric Surgery Across the IFSO Chapters: Key Insights on the Baseline Patient Demographics, Procedure Types, and Mortality from the Eighth IFSO Global Registry ReportObesity Surgery, 2024
- Long-Term Outcomes of Medical Management vs Bariatric Surgery in Type 2 DiabetesJAMA, 2024
- Metabolic syndrome is a predictor of decreased renal function among community-dwelling middle-aged and elderly JapaneseInternational Urology and Nephrology, 2019
- Effect of Roux-en-Y gastric bypass surgery on diabetes remission and complications in individuals with type 2 diabetes: a Danish population-based matched cohort studyDiabetologia, 2019
- Metabolically Healthy Obesity and Risk of Kidney Function DeclineObesity, 2018
- Effect of Low-Fat vs Low-Carbohydrate Diet on 12-Month Weight Loss in Overweight Adults and the Association With Genotype Pattern or Insulin SecretionJAMA, 2018
- Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney FailureJAMA, 2016
- The myth of the metabolic syndromeDiabetologia, 2005